The underlying mechanism revealed that SPON2 activated the nuclear factor-κB (NF-κB) signaling pathway, leading to the upregulation of matrix metalloproteinase 2 (MMP2) and MMP9, both known to promote cancer cell migration and invasion. This evidence concerns the gene SPON2 and cancer.